Baseline characteristics and three-month data from patients receiving Faricimab or Port Delivery System for neovascular age-related macular degeneration or diabetic macular oedema in the real-world VOYAGER Study
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要